Post a Comment Print Share on Facebook
Featured Capitol Rotunda

reads.

The hope of new blodfettssänkare
"The hope of new blodfettssänkare"

"For patients with elevated lipids in the blood and that can not withstand the so-called statins, which are given in the day, can bempediksyra be a complement in the future, writes Läkemedelsvärlden."

"In a phase III study, which has been published in the New England Journal of Medicine , the substance shown to reduce LDL-cholesterol in patients with elevated blood lipid levels, with just over 18 per cent after twelve weeks of treatment."

"– There are already quite a number of medicines to lower blood fats that can be combined in different ways, but for those who can't take statins would bempediksyra could be an option in the long term, " says Anders G. Olsson, seniorprofessor at Linköping university, to Läkemedelsvärlden."

"A disturbing discovery, however, was that the number of deaths one month after the last behandlingsdos was 13 of the 1 488 people in the group that received bempediksyra, compared with two out of 742 in the placebo group. To investigate this further, a new, major phase III study underway. Includes 12 600 persons and the study is expected to be completed in 2022."

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.